News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO): Insulin Degludec Passed the Review by the First Committee on Drugs of Pharmaceutical Affairs in Japan


9/4/2012 9:04:48 AM

BAGSVAERD, DENMARK--(Marketwire - August 31, 2012) - Company Announcement No 54 2012: http://hugin.info/2013/R/1638160/526921.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1638160]


Novo Nordisk A/S
Novo Alle , DK-2880 Bagsvaerd, Danmark
T. Tlf. +45 44 44 88 88
F. Fax +45 44 44 49 05


Read at BioSpace.com
Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES